D
Disc Medicine, Inc. (IRON)
NGM – Real vaqt narxi. Valyuta: USD
74.78
+4.62 (6.58%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
78.44
+3.66 (4.89%)
Bozordan keyin: Jun 26, 2026, 7:48 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
74.78
+4.62 (6.58%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
78.44
+3.66 (4.89%)
Bozordan keyin: Jun 26, 2026, 7:48 PM EDT
| Tarkibi | |
|---|---|
| 7.78% | Insayderlar egalik qilgan aksiyalar ulushi |
| 113.72% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 123.32% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 291 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| FMR, LLC | 5.59M | 2026-03-31 | 14.63% | $395.50M |
| RA Capital Management, L.P. | 2.45M | 2026-03-31 | 6.41% | $173.45M |
| Blackrock Inc. | 2.27M | 2026-03-31 | 5.95% | $160.96M |
| Wellington Management Group, LLP | 1.74M | 2026-03-31 | 4.54% | $122.85M |
| State Street Corporation | 1.70M | 2026-03-31 | 4.45% | $120.22M |
| Price (T.Rowe) Associates Inc | 1.55M | 2026-03-31 | 4.06% | $109.68M |
| Atlas Venture Life Science Advisors, LLC | 1.51M | 2026-03-31 | 3.96% | $107.17M |
| Vanguard Capital Management LLC | 1.38M | 2026-03-31 | 3.60% | $97.37M |
| JPMORGAN CHASE & CO | 1.37M | 2026-03-31 | 3.59% | $97.09M |
| Frazier Life Sciences Management, L.P. | 1.35M | 2026-03-31 | 3.55% | $95.91M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 1.87M | 2026-04-30 | 4.89% | $132.28M |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.66M | 2026-02-28 | 4.34% | $113.09M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.13M | 2026-04-30 | 2.96% | $80.09M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 988,969 | 2026-03-31 | 2.59% | $70.01M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 690,000 | 2026-04-30 | 1.81% | $48.85M |
| iShares Trust-iShares Russell 2000 ETF | 647,055 | 2026-04-30 | 1.69% | $45.81M |
| T. Rowe Price New Horizons Fund, Inc. | 504,986 | 2026-03-31 | 1.32% | $35.75M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 494,474 | 2026-04-30 | 1.29% | $35.00M |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 398,364 | 2026-02-28 | 1.04% | $28.20M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 395,235 | 2026-03-31 | 1.03% | $27.98M |
| T. Rowe Price Health Sciences Fund, Inc. | 394,643 | 2025-12-31 | 1.03% | $25.97M |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 385,709 | 2026-03-31 | 1.01% | $27.30M |